These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 15753533

  • 1. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D.
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [Abstract] [Full Text] [Related]

  • 2. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF.
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [Abstract] [Full Text] [Related]

  • 3. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L.
    Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
    [Abstract] [Full Text] [Related]

  • 4. In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD.
    Memoli B, Grandaliano G, Soccio M, Postiglione L, Guida B, Bisesti V, Esposito P, Procino A, Marrone D, Michael A, Andreucci M, Schena FP, Pertosa G.
    J Am Soc Nephrol; 2005 Apr; 16(4):1099-107. PubMed ID: 15716332
    [Abstract] [Full Text] [Related]

  • 5. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 6. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 7. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y, Wang Y, Qi L.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan 04; 36(1):18-9. PubMed ID: 11778537
    [Abstract] [Full Text] [Related]

  • 8. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
    Tesar V, Jirsa M, Zima T, Kalousová M, Bartunková J, Stejskalová A, Dostál C, Zabka J.
    Med Sci Monit; 2002 Jan 04; 8(1):BR24-9. PubMed ID: 11782670
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.
    J Rheumatol; 1998 Feb 04; 25(2):308-13. PubMed ID: 9489824
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction.
    Jouvenne P, Vannier E, Dinarello CA, Miossec P.
    Arthritis Rheum; 1998 Jun 04; 41(6):1083-9. PubMed ID: 9627018
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T, Sato S, Hasegawa M, Ihn H, Takehara K.
    J Rheumatol; 2000 Aug 04; 27(8):1917-21. PubMed ID: 10955333
    [Abstract] [Full Text] [Related]

  • 12. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I.
    Am J Gastroenterol; 1995 Aug 04; 90(8):1301-6. PubMed ID: 7639234
    [Abstract] [Full Text] [Related]

  • 13. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T, Goll R, Cui G, Husebekk A, Vonen B, Birketvedt GS, Florholmen J.
    Scand J Gastroenterol; 2007 Nov 04; 42(11):1312-20. PubMed ID: 17852866
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997 Nov 04; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting.
    Wei M, Kuukasjärvi P, Laurikka J, Pehkonen E, Kaukinen S, Laine S, Tarkka M.
    Cytokine; 2001 Aug 21; 15(4):223-8. PubMed ID: 11563882
    [Abstract] [Full Text] [Related]

  • 16. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
    Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN.
    J Immunol; 1998 Nov 01; 161(9):4992-9. PubMed ID: 9794436
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6.
    Gaillard JP, Mani JC, Liautard J, Klein B, Brochier J.
    Eur Cytokine Netw; 1999 Mar 01; 10(1):43-8. PubMed ID: 10210772
    [Abstract] [Full Text] [Related]

  • 18. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun 01; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
    Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP.
    Genes Immun; 2000 Feb 01; 1(3):185-90. PubMed ID: 11196710
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.